<font color="red">Protection_1</font> of man from <font color="red">natural_1</font> <font color="red">infection_1</font> <font color="red">with_1</font> <font color="red">influenza_1</font> <font color="red">A2_1</font> Hong Kong virus by amantadine : a controlled field trial . 
<br>
<br> <font color="red">Prophylactic_1</font> <font color="red">administration_1</font> <font color="red">of_1</font> <font color="red">amantadine_1</font> <font color="red">in_1</font> <font color="red">doses_1</font> <font color="red">of_1</font> <font color="red">100_1</font> <font color="red">mg_1</font> <font color="red">._1</font> <font color="red">twice_1</font> <font color="red">a_1</font> <font color="red">day_1</font> <font color="red">offered_1</font> <font color="red">statistically_1</font> <font color="red">significant_1</font> <font color="red">protection_3</font> <font color="red">against_3</font> <font color="red">influenza_3</font> <font color="red">A2_3</font> <font color="red">infection_3</font> in a double - blind field trial involving 391 medical student volunteers during the influenza A2 Hong Kong epidemic in Helsinki in the winter of 1969 . <font color="red">Serologically_3</font> <font color="red">verified_3</font> <font color="red">influenza_3</font> <font color="red">,_3</font> <font color="red">as_1</font> <font color="red">measured_1</font> <font color="red">by_1</font> <font color="red">complement_3</font> <font color="red">fixation_3</font> <font color="red">and/or_3</font> <font color="red">haemagglutination_3</font> <font color="red">inhibition_3</font> <font color="red">,_3</font> <font color="red">occurred_1</font> in 27 out of 192 students in the amantadine group against 57 out of 199 in the placebo group , giving a protection rate of 52% .